Display options
Share it on

CNS Drugs. 2018 Dec;32(12):1185. doi: 10.1007/s40263-018-0585-6.

Correction to: Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain.

CNS drugs

John A Hey, Petr Kocis, Jakub Hort, Susan Abushakra, Aidan Power, Martin Vyhnálek, Jeremy Y Yu, Martin Tolar

Affiliations

  1. Alzheon, Inc, 111 Speen Street Suite 306, Framingham, MA, 01701, USA. [email protected].
  2. Alzheon, Inc, 111 Speen Street Suite 306, Framingham, MA, 01701, USA.
  3. International Clinical Research Centre, St. Anne's University Hospital Brno, Brno, Czech Republic.
  4. Department of Neurology, Cognitive Center, 2nd Faculty of Medicine, Motol University Hospital, Charles University, Prague, Czech Republic.

PMID: 30421245 PMCID: PMC6828218 DOI: 10.1007/s40263-018-0585-6

Abstract

Page 856: Fig. 6 was an incorrect duplication of Fig. 5. The correct figure is given below.

Publication Types